Manufacturing News AstraZeneca invests $200m in local manufacturing capability Global biopharmaceuticals manufacturer AstraZeneca has committed $200 million to the company’s facility in North Ryde, Sydney. The investment will go towards increasing the facility’s production capabilities,Read More Tajna BiscevicFebruary 11, 2020, 9:43 amFebruary 11, 2020 0 131